Characteristics and outcomes in patients with atrial fibrillation receiving direct oral anticoagulants in off-label doses

BACKGROUND: We evaluated adherence to dosing criteria for patients with atrial fibrillation (AF) taking dabigatran or rivaroxaban and the impact of off-label dosing on thromboembolic and bleeding risk. METHODS: We used data for a retrospective cohort from a large U.S. health plan for Medicare benefi...

Descripción completa

Detalles Bibliográficos
Autores principales: Briasoulis, Alexandros, Gao, Yubo, Inampudi, Chakradhari, Alvarez, Paulino, Asleh, Rabea, Chrischilles, Elizabeth, Leira, Enrique C., Vaughan-Sarrazin, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998084/
https://www.ncbi.nlm.nih.gov/pubmed/32013886
http://dx.doi.org/10.1186/s12872-020-01340-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998084/
https://www.ncbi.nlm.nih.gov/pubmed/32013886
http://dx.doi.org/10.1186/s12872-020-01340-4

Ejemplares similares